Injection site reactions and nausea: Reactions at the site of injection which can include pain, redness, and swelling at the site of the injection, are common
Modern metabolic research focuses heavily on triple hormone receptor agonists engineered to stimulate glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptors simultaneously
Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RGH, Howe PRC, et al
Senate Finance Committee report revealed, three companies Novo Nordisk, Sanofi and Eli Lilly control 99 percent of the marketplace and have worked in lockstep to limit competition and increase prices: Over The Past Decade, The Three Largest Manufacturers Of Insulin Novo Nordisk, Sanofi And Eli Lilly Aggressively Raised The List Price Of Their Insulin Products Absent Significant Advances In The Efficacy Of The Drugs. Sanofis long-acting insulin pens, Lantus SoloStar, increased from $303 in 2014 to $404 in 2019
Viruses , 14:2486